SNCA and Parkinson disease: In PD, most of the studies have been performed with ASO mice (α-synuclein overexpressing) to stimulate the production of αSyn in the central nervous system [173] and with Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) [174].